Oakworth Capital, Inc. Pfizer Inc Transaction History

Oakworth Capital, Inc.

$1.45 Billion
Q4 2024

A detailed history of Oakworth Capital, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Oakworth Capital, Inc. holds 28,655 shares of PFE stock, worth $737,579. This represents 0.05% of its overall portfolio holdings.

Number of Shares

28,655

Previous 65,096 55.98%

Holding current value

$737,579

Previous $1.88 Million 59.64%

% of portfolio

0.05%

Previous 0.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$24.8 - $30.19 $903,736 - $1.1 Million	-36,441 Reduced 55.98%	28,655 $760,000
Q3 2024 Oct 21, 2024	SELL	$27.7 - $31.39 $55,649 - $63,062	-2,009 Reduced 2.99%	65,096 $1.88 Million
Q2 2024 Jul 19, 2024	SELL	$25.26 - $29.6 $28,796 - $33,744	-1,140 Reduced 1.67%	67,105 $1.88 Million
Q1 2024 Apr 22, 2024	BUY	$25.89 - $29.73 $199,689 - $229,307	7,713 Added 12.74%	68,245 $1.89 Million
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $418,341 - $543,379	-16,010 Reduced 20.92%	60,532 $1.74 Million
Q3 2023 Oct 31, 2023	SELL	$32.09 - $37.51 $20,665 - $24,156	-644 Reduced 0.83%	76,542 $2.54 Million
Q2 2023 Jul 28, 2023	BUY	$36.12 - $41.79 $19,251 - $22,274	533 Added 0.7%	77,186 $2.83 Million
Q1 2023 May 02, 2023	BUY	$39.39 - $51.28 $56,445 - $73,484	1,433 Added 1.91%	76,653 $3.13 Million
Q4 2022 Feb 03, 2023	SELL	$41.75 - $54.5 $53,982 - $70,468	-1,293 Reduced 1.69%	75,220 $3.86 Million
Q3 2022 Oct 31, 2022	SELL	$43.76 - $53.42 $1,750 - $2,136	-40 Reduced 0.05%	76,513 $3.35 Million
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $30,291 - $35,915	651 Added 0.86%	76,553 $4.01 Million
Q1 2022 Apr 11, 2022	BUY	$45.75 - $56.69 $71,507 - $88,606	1,563 Added 2.1%	75,902 $3.93 Million
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $115,448 - $171,132	-2,794 Reduced 3.62%	74,339 $4.39 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $116,611 - $149,797	-2,971 Reduced 3.71%	77,133 $3.32 Million
Q2 2021 Jul 20, 2021	SELL	$35.91 - $40.68 $218,153 - $247,131	-6,075 Reduced 7.05%	80,104 $3.14 Million
Q1 2021 Apr 30, 2021	SELL	$33.49 - $37.77 $312,863 - $352,847	-9,342 Reduced 9.78%	86,179 $3.12 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $88,026 - $111,932	-2,630 Reduced 2.68%	95,521 $3.52 Million
Q3 2020 Nov 09, 2020	BUY	$31.75 - $37.25 $18,510 - $21,716	583 Added 0.6%	98,151 $3.6 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $65,541 - $79,511	-2,176 Reduced 2.18%	97,568 $3.19 Million
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $217,104 - $310,195	-8,032 Reduced 7.45%	99,744 $3.26 Million
Q4 2019 Jan 31, 2020	SELL	$32.92 - $37.36 $72,325 - $82,079	-2,197 Reduced 2.0%	107,776 $4.21 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $106,989 - $138,734	-3,293 Reduced 2.91%	109,973 $3.95 Million
Q2 2019 Aug 02, 2019	SELL	$36.98 - $41.52 $50,884 - $57,131	-1,376 Reduced 1.2%	113,266 $4.91 Million
Q1 2019 May 06, 2019	SELL	$37.5 - $41.2 $693,675 - $762,117	-18,498 Reduced 13.89%	114,642 $4.87 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $9,194 - $10,482	239 Added 0.18%	133,140 $5.81 Million
Q3 2018 Oct 25, 2018	SELL	$34.47 - $41.81 $2.05 Million - $2.49 Million	-59,499 Reduced 30.92%	132,901 $5.86 Million
Q2 2018 Aug 07, 2018	SELL	$32.98 - $35.16 $464,886 - $495,615	-14,096 Reduced 6.83%	192,400 $6.98 Million
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $16,848 - $19,546	-528 Reduced 0.26%	206,496 $7.56 Million
Q4 2017 Jan 22, 2018	BUY	$33.26 - $35.29 $91,598 - $97,188	2,754 Added 1.35%	207,024 $7.5 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $6.33 Million - $6.98 Million	204,270	204,270 $6.93 Million

Others Institutions Holding PFE

# of Institutions

3,244

Shares Held

3.65B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oakworth Capital, Inc. with notifications on news.

Account

Oakworth Capital, Inc. Pfizer Inc Transaction History